BDBM498895 (3S,4R)-1-(N~2~- cyclohexyl-D-lysyl)-4- {[(5-methyl-1,3-thiazol- 2-yl)carbonyl]amino}- N-(thiophen-2- ylmethyl)piperidine-3- carboxamide::US11014920, Compound 3

SMILES Cc1cnc(s1)C(=O)N[C@@H]1CCN(C[C@@H]1C(=O)NCc1cccs1)C(=O)[C@@H](CCCCN)NC1CCCCC1

InChI Key InChIKey=WCKNQCHPORNTNR-RBZQAINGSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 498895   

TargetCoagulation factor XII(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM498895((3S,4R)-1-(N~2~- cyclohexyl-D-lysyl)-4- {[(5-methy...)
Affinity DataIC50:  109nMAssay Description:Factor XIIa activity determinations were made in 50 mM HEPES buffer containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent